Arylamine N-acetyltransferase activity in bronchial epithelial cells and its inhibition by cellular oxidants

Toxicology and Applied Pharmacology

Volumn 236, Issue 3, 2009, Pages 366-371

  Dairou, Julien ^a   Petit, Emile ^a   Ragunathan, Nilusha ^a   Baeza Squiban, Armelle ^a   Marano, Francelyne ^a   Dupret, Jean Marie ^a   Rodrigues Lima, Fernando ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Aromatic amine pollutants; Arylamine N acetyltransferases; Lung; Oxidative stress; Xenobiotic metabolism

Indexed keywords

2 FLUORENYLAMINE; 2 NAPHTHYLAMINE; 4 BIPHENYLAMINE; AMINOSALICYLIC ACID; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; ARYLAMINE N ACETYLTRANSFERASE 1; ARYLAMINE N ACETYLTRANSFERASE 2; BENZIDINE; CARCINOGEN; HYDROGEN PEROXIDE; OXIDIZING AGENT; PEROXYNITRITE; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ACETYLATION; AIR POLLUTANT; AIR POLLUTION; ARTICLE; BIOTRANSFORMATION; BRONCHUS MUCOSA; CLARA CELL; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXPOSURE; HUMAN; HUMAN CELL; INFLAMMATION; INHALATION; LUNG ALVEOLUS CELL TYPE 2; LUNG TOXICITY; NITROSATIVE STRESS; OXIDATIVE STRESS;

2-NAPHTHYLAMINE; ACETYLATION; AMINOBIPHENYL COMPOUNDS; ARYLAMINE N-ACETYLTRANSFERASE; BIOTRANSFORMATION; BRONCHI; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; OXIDANTS; PEROXYNITROUS ACID;

MURINAE; NICOTIANA TABACUM;

EID: 63649098086     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.02.010     Document Type: Article

References (64)

1. Atmane N., Dairou J., Paul A., Dupret J.M., and Rodrigues-Lima F. Redox regulation of the human xenobiotic metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1). Reversible inactivation by hydrogen peroxide. J. Biol. Chem. 278 (2003) 35086-35092
2. Badawi A.F., Hirvonen A., Bell D.A., Lang N.P., and Kadlubar F.F. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res. 55 (1995) 5230-5237
3. Baeza A., and Marano F. [Air pollution and respiratory diseases: a central role for oxidative stress]. Med. Sci. (Paris) 23 (2007) 497-501
4. Barker D.F., Walraven J.M., Ristagno E.H., Doll M.A., States J.C., and Hein D.W. Quantitative tissue and gene specific differences and developmental changes in Nat1, Nat2 and Nat3 mRNA expression in the rat. Drug Metab Dispos. 36 (2008) 2445-2451
5. Biswas, S.K., Rahman, I., in press. Environmental toxicity, redox signaling and lung 420 inflammation: the role of glutathione. Mol. Aspects Med.
6. Boelsterli U. Mechanistic Toxicology. The Molecular Basis of How Chemicals Disrupt Biological Targets (2003), Taylor and Francis Group, London and New-York
7. Bouchardy C., Mitrunen K., Wilkman H., Husgafvel-Pursiainen K., Dayer P., Benhamou S., and Hirvonen A. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk. Pharmacogenetics 8 (1998) 291-298
8. Bouchardy C., Benhamou S., Jourenkova N., Dayer P., and Hirvonen A. Metabolic genetic polymorphisms and susceptibility to lung cancer. Lung Cancer 32 (2001) 109-112
9. Butcher N.J., Ilett K.F., and Minchin R.F. Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. Mol. Pharmacol. 57 (2000) 468-473
10. Butcher N., Boukouvala S., Sim E., and Minchin R.F. Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J 2 (2002) 30-42
11. Castell J.V., Donato M.T., and Gomez-Lechon M.J. Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach. Exp. Toxicol. Pathol. 57 Suppl. 1 (2005) 189-204
12. Castillo S.S., Levy M., Thaikoottathil J.V., and Goldkorn T. Reactive nitrogen and oxygen species activate different sphingomyelinases to induce apoptosis in airway epithelial cells. Exp. Cell Res. 313 (2007) 2680-2686
13. Cornish V., Pinter K., Boukouvala S., Johnson N., Labrousse C., Payton M., Priddle H., Smith A.J.H., and Sim E. Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene. Pharmacogenomics J. 3 (2003) 169-177
14. Cozens A.L., Yezzi M.J., Kunzelmann K., Ohrui T., Chin L., Eng K., Finkbeiner W.E., Widdicombe J.H., and Gruenert D.C. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10 (1994) 38-47
15. Dairou J., Atmane N., Dupret J.M., and Rodrigues-Lima F. Reversible inhibition of the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 by S-nitrosothiols. Biochem. Biophys. Res. Commun. 307 (2003) 1059-1065
16. Dairou J., Atmane N., Rodrigues-Lima F., and Dupret J.M. Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells. A cellular and mechanistic study. J. Biol. Chem. 279 (2004) 7708-7714
17. Dairou J., Dupret J.M., and Rodrigues-Lima F. Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells. FEBS Lett. 579 (2005) 4719-4723
18. Dairou J., Malecaze F., Dupret J.M., and Rodrigues-Lima F. The xenobiotic-metabolizing enzymes arylamine N-acetyltransferases (NAT) in human lens epithelial cells: inactivation by cellular oxidants and UVB-induced oxidative stress. Mol. Pharmacol. 67 (2005) 1299-1306
19. Dazy A.C., Auger F., Bailbe D., Blouquit S., Lombet A., and Marano F. The toxicity of H2O2 on the ionic homeostasis of airway epithelial cells in vitro. Toxicol. In Vitro 17 (2003) 575-580
20. Dimova S., Hoet P.H., and Nemery B. Xenobiotic-metabolizing enzyme activities in primary cultures of rat type II pneumocytes and alveolar macrophages. Drug Metab. Dispos. 29 (2001) 1349-1354
21. Dupret J.M., and Rodrigues-Lima F. Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferases. Curr. Med. Chem. 12 (2005) 311-318
22. Foster K.A., Oster C.G., Mayer M.M., Avery M.L., and Audus K.L. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp. Cell Res. 243 (1998) 359-366
23. Gemignani F., Landi S., Szeszenia-Dabrowska N., Zaridze D., Lissowska J., Rudnai P., Fabianova E., Mates D., Foretova L., Janout V., Bencko V., Gaborieau V., Gioia-Patricola L., Bellini I., Barale R., Canzian F., Hall J., Boffetta P., Hung R.J., and Brennan P. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 28 (2007) 1287-1293
24. Grant D.M., Blum M., Beer M., and Meyer U.A. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol. 39 (1991) 184-191
25. Grant D.M., Goodfellow G.H., Sugamori K., and Durette K. Pharmacogenetics of the human arylamine N-acetyltransferases. Pharmacology 61 (2000) 204-211
26. Halliwell B., and Gutteridge J.M.C. Free Radicals in Biology and Medicine (2007), Oxford university Press, Oxford
27. Hanna P.E. N-acetyltransferases, O-acetyltransferases, and N,O-acetyltransferases: enzymology and bioactivation. Adv. Pharmacol. 27 (1994) 401-430
28. Hein D. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat. Res. 65 (2002) 506-507
29. Hein D.W. N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene 25 (2006) 1649-1658
30. Hein D., McQueen C., Grant D., Goodfellow G., Kadlubar F., and Weber W. Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber. Drug Metab. Dispos. 28 (2000) 1425-1432
31. Hein D.W., Doll M.A., Nerland D.E., and Fretland A.J. Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster. Mol. Carcinog. 45 (2006) 230-238
32. Husain A., Zhang X., Doll M.A., States J.C., Barker D.F., and Hein D.W. Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues. Drug Metab. Dispos. 35 (2007) 721-727
33. Kuwano K., Nakashima N., Inoshima I., Hagimoto N., Fujita M., Yoshimi M., Maeyama T., Hamada N., Watanabe K., and Hara N. Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. Eur. Respir. J. 21 (2003) 232-240
34. Kawamura A., Westwood I., Wakefield L., Long H., Zhang N., Walters K., Redfield C., and Sim E. Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1. Biochem. Pharmacol. 75 (2008) 1550-1560
35. Lee S., Yang K., Kwon J., Lee C., Jeong W., and Rhee S. Reversible inactivation of the tumor suppressor PTEN by H2O2. J. Biol. Chem. 277 (2002) 20336-20342
36. Lin H., Kent U., Zhang H., Waskell L., and Hollenberg P. Mutation of tyrosine 190 to alanine eliminates the inactivation of cytochrome P450 2B1 by peroxynitrite. Chem. Res. Toxicol. 16 (2003) 129-136
37. Liu L., Wagner C.R., and Hanna P.E. Human arylamine N-acetyltransferase 1: in vitro and intracellular inactivation by nitrosoarene metabolites of toxic and carcinogenic arylamines. Chem. Res. Toxicol. 21 (2008) 2005-2016
38. Mace K., Bowman E.D., Vautravers P., Shields P.G., Harris C.C., and Pfeifer A.M. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur. J. Cancer 34 (1998) 914-920
39. Magdaleno S.M., Wang G., Jackson K.J., Ray M.K., Welty S., Costa R.H., and DeMayo F.J. Interferon-gamma regulation of Clara cell gene expression: in vivo and in vitro. Am. J. Physiol. 272 (1997) L1142-1151
40. Meij J.T., Haselton C.L., Hillman K.L., Muralikrishnan D., Ebadi M., and Yu L. Differential mechanisms of nitric oxide- and peroxynitrite-induced cell death. Mol. Pharmacol. 66 (2004) 1043-1053
41. Mihm M., and Bauer J. Peroxynitrite-induced inhibition and nitration of cardiac myofibrillar creatine kinase. Biochimie 84 (2002) 1013-1019
42. Minchin R.F., and Boyd M.R. Localization of metabolic activation and deactivation systems in the lung: significance to the pulmonary toxicity of xenobiotics. Annu. Rev. Pharmacol. Toxicol. 23 (1983) 217-238
43. Mueller S., Pantopoulos K., Hubner C., Stremmel W., and Hentze M. IRP1 activation by extracellular oxidative stress in the perfused rat liver. J. Biol. Chem. 276 (2001) 23192-23196
44. Palmiotto G., Pieraccini G., Moneti G., and Dolara P. Determination of the levels of aromatic amines in indoor and outdoor air in Italy. Chemosphere 43 (2001) 355-361
45. Ragunathan N., Dairou J., Pluvinage B., Martins M., Petit E., Janel N., Dupret J.M., and Rodrigues-Lima F. Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition. Mol. Pharmacol. 73 (2008) 1761-1768
46. Rahman I., Biswas S.K., and Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur. J. Pharmacol. 533 (2006) 222-239
47. Ravid T., Sweeney C., Gee P., Carraway III K., and Goldkorn T. Epidermal growth factor receptor activation under oxidative stress fails to promote c-Cbl mediated down-regulation. J. Biol. Chem. 277 (2002) 31214-31219
48. Ricciardolo F.L., Di Stefano A., Sabatini F., and Folkerts G. Reactive nitrogen species in the respiratory tract. Eur. J. Pharmacol. 533 (2006) 240-252
49. Rodrigues-Lima F., Cooper R., Goudeau B., Atmane N., Chamagne A., Butler-Browne G., Sim E., Vicart P., and Dupret J. Skeletal muscles express the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase. J. Histochem. Cytochem. 51 (2003) 789-796
50. Rodrigues-Lima F., Dairou J., Diaz C.L., Rubio M.C., Sim E., Spaink H.P., and Dupret J.M. Cloning, functional expression and characterization of Mesorhizobium loti arylamine N-acetyltransferases:rhizobial symbiosis supplies leguminous plants with the xenobiotic N-acetylation pathway. Mol. Microbiol. 60 (2006) 505-512
51. Rodrigues-Lima F., Dairou J., and Dupret J.M. Effect of environmental substances on the activity of arylamine N-acetyltransferases. Curr. Drug Metab. 9 (2008) 505-509
52. Sadeghi-Hashjin G., Folkerts G., Henricks P.A., Muijsers R.B., and Nijkamp F.P. Peroxynitrite in airway diseases. Clin. Exp. Allergy 28 (1998) 1464-1473
53. Sim E., Westwood I., and Fullam E. Arylamine N-acetyltransferases. Expert Opin. Drug Metab. Toxicol. 3 (2007) 169-184
54. Simon-Deckers A., Gouget B., Mayne-L'hermite M., Herlin-Boime N., Reynaud C., and Carriere M. In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in A549 human pneumocytes. Toxicology 253 (2008) 137-146
55. Singh R.J., Hogg N., Joseph J., Konorev E., and Kalyanaraman B. The peroxynitrite generator, SIN-1, becomes a nitric oxide donor in the presence of electron acceptors. Arch. Biochem. Biophys. 361 (1999) 331-339
56. Stachowiak O., Dolder M., Wallimann T., and Richter C. Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation. J. Biol. Chem. 273 (1998) 16694-16699
57. Tafazoli S., Mashregi M., and O'Brien P.J. Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model. Toxicol. Appl. Pharmacol. 229 (2008) 94-101
58. Van Winkle L.S., Buckpitt A.R., and Plopper C.G. Maintenance of differentiated murine Clara cells in microdissected airway cultures. Am. J. Respir. Cell Mol. Biol. 14 (1996) 586-598
59. Wakefield L., Robinson J., Long H., Ibbitt J.C., Cooke S., Hurst H.C., and Sim E. Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors. Genes Chromosomes Cancer 47 (2008) 118-126
60. Windmill K.F., McKinnon R.A., Zhu X., Gaedigk A., Grant D.M., and McManus M.E. The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies. Mutat. Res. 376 (1997) 153-160
61. Windmill K.F., Gaedigk A., Hall P.M., Samaratunga H., Grant D.M., and McManus M.E. Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Toxicol. Sci. 54 (2000) 19-29
62. Wong P., Eiserich J., Reddy S., Lopez C., Cross C., and van der Vliet A. Inactivation of Glutathione S-transferase by nitric oxide-derived oxidants: exploring a role for tyrosine nitration. Arch. Biochem. Biophys. 394 (2001) 216-228
63. Wu H.C., Lu H.F., Hung C.F., and Chung J.G. Inhibition by vitamin C of DNA adduct formation and arylamine N-acetyltransferase activity in human bladder tumor cells. Urol. Res. 28 (2000) 235-240
64. Zhang J.Y., Wang Y., and Prakash C. Xenobiotic-metabolizing enzymes in human lung. Curr. Drug Metab. 7 (2006) 939-948